CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
about
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.CK2-An Emerging Target for Neurological and Psychiatric Disorders.
P2860
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@en
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@nl
type
label
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@en
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@nl
prefLabel
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@en
CK2 targeted RNAi therapeutic ...... in xenograft prostate tumors.
@nl
P2093
P2860
P356
P1433
P1476
CK2 targeted RNAi therapeutic ...... e in xenograft prostate tumors
@en
P2093
Betsy T Kren
Cheryl L Zimmerman
Daniel P Shaughnessy
Gloria A Niehans
Gretchen M Unger
Khalil Ahmed
Lucas Nacusi
Md Joynal Abedin
Scott M Dehm
Vicci L Korman
P2860
P304
61789-61805
P356
10.18632/ONCOTARGET.11442
P407
P577
2016-09-01T00:00:00Z